Kabra Drugs Limited (BOM:524322)
25.43
-0.67 (-2.57%)
At close: Jun 17, 2026
Kabra Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 105.82 | 212.99 | 26.71 | 0.03 | 0.01 |
Short-Term Investments | 0.44 | 0.44 | 0.44 | - | - |
Cash & Short-Term Investments | 106.26 | 213.43 | 27.15 | 0.03 | 0.01 |
Cash Growth | -50.21% | 686.23% | 91932.82% | 133.67% | -87.10% |
Accounts Receivable | 707.76 | 6.01 | 6.01 | 6 | 6 |
Receivables | 707.76 | 6.01 | 6.01 | 6.44 | 6.72 |
Other Current Assets | 25.22 | 32.19 | 12.33 | 0.33 | 0.33 |
Total Current Assets | 839.23 | 251.62 | 45.48 | 6.8 | 7.06 |
Property, Plant & Equipment | 8.35 | 0.44 | - | - | - |
Other Intangible Assets | 0.07 | - | - | - | - |
Other Long-Term Assets | 0.33 | 0.23 | 0.23 | 0.23 | 0.23 |
Total Assets | 862.71 | 252.29 | 45.72 | 7.04 | 7.3 |
Accounts Payable | 548.35 | - | - | - | - |
Short-Term Debt | 4.29 | 4.37 | 17.09 | 13.82 | 10.26 |
Current Portion of Leases | 0.3 | - | - | - | - |
Current Income Taxes Payable | 5.08 | - | - | - | - |
Other Current Liabilities | 7.39 | 1.37 | 17.8 | 0.53 | 0.97 |
Total Current Liabilities | 565.4 | 5.74 | 34.89 | 14.35 | 11.23 |
Long-Term Leases | 1.1 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 0.06 | 0.01 | - | - | - |
Other Long-Term Liabilities | - | - | -0 | 0 | 0 |
Total Liabilities | 566.56 | 5.74 | 34.89 | 14.35 | 11.23 |
Common Stock | 237.08 | 237.08 | 43.89 | 43.89 | 43.89 |
Retained Earnings | 59.07 | 9.47 | -58.56 | -51.2 | -47.82 |
Comprehensive Income & Other | -0 | -0 | 25.5 | - | - |
Shareholders' Equity | 296.14 | 246.55 | 10.83 | -7.31 | -3.93 |
Total Liabilities & Equity | 862.71 | 252.29 | 45.72 | 7.04 | 7.3 |
Total Debt | 5.69 | 4.37 | 17.09 | 13.82 | 10.26 |
Net Cash (Debt) | 100.57 | 209.06 | 10.06 | -13.79 | -10.25 |
Net Cash Growth | -51.89% | 1977.87% | - | - | - |
Net Cash Per Share | 4.24 | 19.13 | 2.29 | -3.14 | -2.33 |
Filing Date Shares Outstanding | 23.63 | 23.71 | 4.39 | 4.39 | 4.39 |
Total Common Shares Outstanding | 23.63 | 23.71 | 4.39 | 4.39 | 4.39 |
Working Capital | 273.84 | 245.88 | 10.6 | -7.54 | -4.16 |
Book Value Per Share | 12.53 | 10.40 | 2.47 | -1.67 | -0.90 |
Tangible Book Value | 296.08 | 246.55 | 10.83 | -7.31 | -3.93 |
Tangible Book Value Per Share | 12.53 | 10.40 | 2.47 | -1.67 | -0.90 |
Machinery | - | 0.44 | - | 1.66 | 1.66 |